EC CERTIFICATE. National Institute for Biological Standards and Control (NIBSC) Blanche Lane South Mimms Potters Bar Hertfordshire EN6 3QG UK

Similar documents
Official Journal of the European Communities COMMISSION

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

Non-reproductive tissues and cells

QUALITY CONTROL Infectious Disease

to be notified: all parties involved in the graduated plan procedure. Annexes

Non-reproductive tissues and cells

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Non-reproductive tissues and cells Recommending authority/ association

Schedule of Accreditation

Structure and duties of Blood service

Non-reproductive tissues and cells

Laboratory Diagnosis of Viral Infections. G. Jamjoom 2005

Non-reproductive tissues and cells

Negative Hepatitis C Reporting and Linkage to Care Outreach

Non-reproductive tissues and cells Recommending authority/ association

For information only: all participants in the graduated plan procedure. 7 January 2013

The Hepatitis B-e antigen-positive

June EQA schemes closed. Information on sample properties. Prof. Dr. Heinz Zeichhardt. Dr. Martin Kammel

HEPATITIS B NON-IMMEDIATE NOTIFICATION EPIDEMIOLOGY PROGRAM

Non-reproductive tissues and cells

The New Regulations - Special IVD Issues

Non-reproductive tissues and cells

Donor Screening in The Region. Vincini GA NRL, Melbourne, Australia

Controls & Calibrators. Disease Quality Controls

Diagnostic Methods of HBV and HDV infections

Annex II (excluding section 4) of Council Directive 93/42/EEC concerning medical devices

Diagnostic Methods of HBV infection. Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO)

HIV Basics: Clinical Tests and Guidelines

READ HIGHLIGHTED CHANGES

Instructions for Use (Version 3-14 th May 2003) Changes from previous version are shown in Red, deletions are shown as ^

Trends in molecular diagnostics

Toronto Declaration: Strategies to control and eliminate viral hepatitis globally. A call for coordinated action

Public Health, Infections and Transplantation

PROPOSAL FOR THE DEVELOPMENT OF AN INTERNATIONAL REFERENCE PREPARATION FOR HEPATITIS D VIRUS RNA

Isolated Hepatitis B Core Antibody

Human diagnostics. Better be Sure: Quantify HDV & HBV viral load. RoboGene product family

Viral Hepatitis Diagnosis and Management

Considerations for Antiretroviral Use in Patients with Hepatitis B Virus & Human Immunodeficiency Syndrome Coinfection

DS-EIA-ANTI-HIV-UNIF (Ab) I DS-EIA-ANTI-HIV-UNIF (Ab) I DS-EIA-ANTI-HIV-UNIF (Ab) I

INSTAND e.v. in cooperation with:

DEVELOPMENT OF AN INTERNATIONAL REFERENCE PREPARATION FOR HEPATITIS D VIRUS RNA - UPDATE

OCCUPATIONAL HEALTH PROTOCOL

The Technical Aspects of Pathogen Testing in Canada. Nancy Angus Canadian Blood Services Director, Testing

June Pre-evaluation of the External Quality Assessment Schemes in Virus Diagnostics. Prof. Dr. Heinz Zeichhardt. Dr.

OCCUPATIONAL HEALTH PROTOCOL

The ABC s (and D & E s) of the Viral Hepatitides Part 2 DIAGNOSTIC TESTS 3/7/2013

Primary Sample Manual Infectious Serology Issue No Effective Date: 20/09/17 Page 1 of 15 EUROFINS BIOMNIS

Product List Autobio Diagnostics. Autobio. autobio diagnostics an autobio group company

The Alphabet Soup of Viral Hepatitis Testing

Standardization: Calibration of. International Standards, reference preparations and working standards. Micha Nübling, PEI

Memo No: Date: 25-Nov NEW Serology and Virology Testing

The testing of Donated Blood and Components at NHSBT

الحترمونا من خري الدعاء

Plasma for fractionation: South African Plasma Requirements

WHO GUIDELINES ON ESTIMATION OF RESIDUAL RISK OF HIV, HBV OR HCV INFECTIONS VIA CELLULAR BLOOD COMPONENTS AND PLASMA

Viral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a

BIO-FLASH. BIOKIT, S.A. - Can Malé s/n Lliçà d Amunt - Barcelona - SPAIN

Non-reproductive tissues and cells Recommending authority/ association

Guidance for Industry

The use of QCMD proficiency testing panels in clinical virology.

The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations Jackson B R, Busch M P, Stramer S L, AuBuchon J P

Screening donors and donations for transfusion transmissible infectious agents. Alan Kitchen

Proposed 1 st IS for Hepatitis E Virus RNA WHO/BS/

Glecaprevir-Pibrentasvir in HCV GT 1 or 4 & Prior DAA Treatment MAGELLAN-1 (Part 2)

Frequency of occult hepatitis B in HBsAg seronegative blood donors in a tertiary care hospital in kerala,south India.

Blood Screening Assays. CTS lab locations where assays are performed are indicated by alpha codes D, P, and T.

Non-reproductive tissues and cells Recommending authority/ association

Hepatitis B and C Overview, Outbreaks, and Recommendations. Viral Hepatitis Language. Types of Viral Hepatitis 7/1/2013

CORD BLOOD TRANSPLANTATION STUDY CBU EXCLUSION AND QUARANTINE RELEASE FORM

AccuSet HBV Worldwide Performance Panel

Currently, the Department of Epidemiology has 5 rooms / offices undertake various professional roles:

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

With the aim of continuous improvement of our products, Biokit increases the shelf life of bioelisa HIV 1+2 Ag/Ab from 10 to 12 months.

Impact of Testing Strategies to Reduce Transmission Risk for HBV. Ravi Reddy, M Vermeulen South African National Blood Service (SANBS) 29 July 2013

Reporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey

Evaluation of run controls for cobas 6800 MPX and HEV assay

INSTAND e.v. in cooperation with:

AccuVert HBV Seroconversion Panel PHM941(M) ( )

DEPARTMENT OF MICROBIOLOGY IMPORTANT NOTICE TO USERS Turnaround Times (TATs) for Microbiology Investigations

PLUNGER ( ) Not applicable. Field Safety Corrective Action (FSCA)

Microbiology EQA Product Portfolio

Elecsys HBsAg II. R2 Anti-HBsAg-Ab~Ru (bpy) 3

Ministry of Health, Screening and Vaccination Requirements from 1 January 2019

MKT/BF/328

MOLECULAR DIAGNOSTIC PANELS and REAGENT KITS for NUCLEIC ACID EXTRACTION and RT-PCR of INFECTIOUS DISEASES and GENOMICS. Sep 2018

ELISA kits for infections (HIV; Hepatitis A, B, C, D, E; Syphilis, ToRCH and others), hormone pathologies and tumor markers.

DAT-B 2015 Direct Antiglobulin Test

Innovative diagnostics for HIV, HBV and HCV

Bible Class: Hepatitis B Virus Infection

Undergraduate Medical Education

United Kingdom National External Quality Assessment Service for Microbiology [Established 1971]

Answering your daily challenges. in the ELISA technology I N FECTI OUS DISEASES. bioelisa

Within 14 days at 2-8⁰C. DO NOT FREEZE WHOLE BLOOD Micro Typing Systems 50 µl plasma

Serology for Biochemists

QSEAL Recovered Plasma Specification

2014/LSIF/PD/025 Malaysia s Approach to Testing Strategies

Khalid Alquthami (Correspondence) Regional Lab, Makkah. Saudi Arabia

Biokit Label Catalog. Living Immunoassay Excellence

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Transcription:

National Institute for Biological Standards and Control (NIBSC) EC Certificate - Full Quality Assurance System Approval Certificate Annex IV (excluding sections 4 and 6) of Council Directive 98/79/EC on In Vitro Diagnostic Medical Devices Scope of Certificate: The design and manufacture of biological standards and controls used for the control of anti-blood group quantitation, HLA tissue typing and markers for Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus, Human Cytomegalovirus, Rubella virus and Toxoplasma gondii Device Classification: and List B Device Descriptions: See Attachments 1-5 Model Type: See Attachments 1-5 We hereby declare that an examination of the full quality assurance system has been carried out per report 4787579443, following the requirements of the national legislation to which the undersigned is subject, transposing Annex IV (with the exemption of sections 4 and 6) of Council Directive 98/79/EC on In Vitro Diagnostic Medical Devices. We certify that the full quality assurance system conforms with the relevant provisions of the aforementioned directive and is subject to periodic surveillance as required by 98/79/EC, Annex IV, Section 5. For Annex II, List A devices where they are covered by this certificate, an EC Design Examination certificate according to 98/79/EC, Annex IV, Section 4 is required. This certificate is issued with 5 attachments listing model numbers listing additional locations covered by this certificate.

Attachment 1 of 5 British Working Standard for HBsAg 07/288-xxx 0.2 IU/mL NIBSC Monitor Sample for HBsAg 07/286-xxx 0.051U/mL British Working Standard for Anti-HIV-1 99/750-xxx British Working Standard for Anti-HIV-1 99/710-xxx 1 in 5 Dilution Monitor Sample for Anti-HIV-2 99/674-xxx Monitor Sample for Anti-HTLV-1 03/104 xxx British Working Standard for Anti-HCV 14/240-xxx British Working Standard for Anti-HCV 10/154-xxx 1 in 8 Dilution British Working Standard for Anti-HCV 14/242-xxx 1 in 8 Dilution The British Standard for Anti-D antibodies 73/515 and 73/517 Annex II List B The British Standard for Anti-c antibodies 84/628 Annex II List B 2nd British Standard for Anti-Rubella Serum, 67/182 Annex II List B Human HLA-A Genotyping Panel 05/208-xxx Annex II List B HLA-DRB1 Genotyping Reference Panel 10/136-xxx Annex II List B

Attachment 2 of 5 HCV RNA Working Reagent for Nucleic Acid 02/264-xxx Amplification Techniques (genotype 3) Hepatitis B Virus DNA Working Reagent for 11/182-xxx Nucleic Acid Amplification Techniques HIV-1 RNA Working Reagent 99/634-xxx HIV-1 RNA Working Reagent 99/636-xxx HBV, HCV and HIV Triplex Reagent (NAT) 14/198-xxx Human Cytomegalovirus for Nucleic Acid 08/314-xxx Annex II List B Amplification Techniques Clinical Virology MultiplexI: 15/130-xxx Annex II List B Immunodeficiencypanel working reagent for Nucleic Acid Amplification Tests (NAT)

Attachment 3 of 5 Anti-HIV-1: Quality Control Serum: QCRHIV1QC1 Anti-HIV-1: Quality Control Serum: Sample 2 QCRHIV1QC2 Anti-HIV-1: Quality Control Serum: Sample 3 QCRHIV1QC3 Anti-HIV-1: Quality Control Serum: Sample 5 QCRHIV1QC5 HIV1 p24 Antigen: Quality Control Serum: QCRHIV1P24QC1 H!V1 p24 Antigen: Quality Control Serum: QCRHIV1P24QC2 Sample 2 Anti-HIV-2: Quality Control Serum: Sample 2 QCRHIV2QC2 Anti-HIV-2: Quality Control Serum: Sample 3 QCRHIV2QC3 Anti-HCV Quality Control Serum: QCRHCVQC1 Anti-HBs Quality Control Serum: QCRHBsQC1 HBsAg Quality Control Serum: QCRHBsGQC1 HBsAg Quality Control Serum: Sample 2 QCRHBsGQC2

Attachment 4 of 5 Anti-HBe Quality Control Serum: QCRHBeQC1 Total Anti-HBc Quality Control Serum: QCRTHBcQC1 Total Anti-HBc Quality Control Serum: QCRTHBcQC2 Sample 2 lgm Anti-HBc Quality Control Serum: QCRHBclgMQC1 HIV-1 Rapid Test Device: Quality Control QCRHIVRTDQC1 Serum: Anti-CMV Quality Control Serum : QCRCMVQC1 Annex II List B IgM Anti-CMV Quality Control Reagent 1 QCRCMVIgMQC1 Annex II List B Anti-Rubella Quality Control Serum: QCRRUBQC1 Annex II List B Anti-Toxoplasma Quality Control Serum: QCRTOXOQC1 Annex II List B Anti-Rubella Quality Control Serum Sample 2 QCRRUBQC2 Annex II List B Anti-Rubella lgm Quality Control Serum QCRRUBlgMQC1 Annex II List B

Attachment 5 of 5 IgM Anti-Toxoplasma gondii Quality Control Reagent 1 QCRTOXOIgMQC1 Annex II List B